​FOUR SARS-COV-2 VACCINE DOSES OR HYBRID IMMUNITY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPIES. A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

Kristin H Bjørlykke  ¹     Hilde S. Ørbo  ²     Anne T. Tveter  ²     Trung T. Tran  ³     Joseph Sexton  ²     Ingrid Jyssum  ²     Ingrid E. Christensen  ²     Grete Kro  ³     Tore K Kvien  ⁴     Jørgen Jahnsen     Ludvig A. Munthe     Adity Chopra     David J. Warren     Gunnveig Grødeland     Espen A Haavardsholm     Siri Mjaaland     Sella A. Provan     John T. Vaage     Silje W. Syversen     Guro    
¹ Akershus University Hospital, Lørenskog, Norway
² Diakonhjemmet Hospital, Oslo, Norway
³ Oslo University Hospital, Oslo, Norway
⁴ University of

Session
Late breaking abstracts III

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)